1 / 1

Natco Pharma rallies for sixth straight day; stock surges 50%

Shares of Natco Pharma share Price has rallied 7% to Rs 2,196, extending its previous day’s 15% surge on the BSE after the company said it has received the approval for the generic anti-hepatitis C medicine sofosbuvir tablets of 400 mg from the Drugs Controller General-India (DCGI).<br>

Roxannepaul89
Télécharger la présentation

Natco Pharma rallies for sixth straight day; stock surges 50%

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Natco Pharma rallies for sixth straight day; stock surges 50% Shares of Natco Pharma share Pricehas rallied 7% to Rs 2,196, extending its previous day’s 15% surge on the BSE after the company said it has received the approval for the generic anti- hepatitis C medicine sofosbuvir tablets of 400 mg from the Drugs Controller General-India (DCGI). Today, the stock opened at Rs 2,080 and hit a fresh record high of Rs 2,264 on BSE. The trading volumes on the counter more than doubled with a combined 526,473 shares changed hands on the BSE and NSE till 1027 hours. The stock of pharmaceutical company rose for a sixth straight session after the company signed a non-exclusive licensing agreement with Gilead Sciences to manufacture and sell generic versions of its chronic hepatitis C medicines in 91 developing countries. It rallied nearly 50% from Rs 1,492 on March 3, 2015 compared with 2.5% fall in the S&P BSE Sensex. Meanwhile, Dilip S Shanghvi, the promoter of Sun Pharmaceutical Industries hold 3.46% stake in Natco Pharma as on December 31, 2014, the shareholding pattern data shows.

More Related